|
23-EPI-26-Deoxyactein (20 mg)
|
|
|
Ecamsule Solution (0.5 mL)
|
|
|
Ecamsule Triethanolamine (200 mg)
|
|
|
Ecamsule Related Compound A (50 mg) (1,4-Phenylenedimethanol)
|
|
|
Ecamsule Related Compound B (50 mg) (4-(Hydroxymethyl)benzoic acid)
|
|
|
Ecamsule Related Compound C (50 mg) (terephthalic acid)
|
|
|
Ecamsule Related Compound D (50 mg) (((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid)
|
|
|
Ecamsule Related Compound E (25 mg) (Sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate)
|
|
|
Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid)
|
|
|
Ecamsule Related Compound G (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt)
|
|
|
Echinacoside (15 mg)
|
|
|
Econazole Nitrate (250 mg)
|
|
|
Econazole Related Compound A (15 mg) (1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)ethanol)
|
|
|
Econazole Related Compound B (15 mg) (2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine nitrate)
|
|
|
Econazole Related Compound C (15 mg) (1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]imidazolium chloride)
|
|
|
Edetate Calcium Disodium (200 mg)
|
|
|
Edetate Disodium (200 mg)
|
|
|
Edetic Acid (200 mg)
|
|
|
Edrophonium Chloride (200 mg)
|
|
|
Efavirenz (200 mg)
|
|
|
Efavirenz Racemic (20 mg) ((+/-)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one)
|
|
|
Efavirenz Related Compound A (20 mg) ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol)
|
|
|
Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)
|
|
|
Efavirenz Related Compound B (10 mg) ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one)
|
|
|
Eflornithine Hydrochloride (150 mg)
|
|
|
Eicosapentaenoic Acid Ethyl Ester (500 mg)
|
|
|
European Elder Berry Dry Extract (1 g)
|
|
|
Eletriptan Hydrobromide (200 mg) (3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole monohydrobromide monohydrate)
|
|
|
Eletriptan Related Compound B (20 mg) ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole)
|
|
|
Eletriptan S-Enantiomer (20 mg) ((S)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole, monohydrobromide)
|
|
|
Eleutheroside B (15 mg) (Syringin)
|
|
|
Eleutheroside E (15 mg) (Beta-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-4,1-phenylene)bis-)
|
|
|
Emedastine Difumarate (100 mg)
|
|
|
Emetine Hydrochloride (300 mg)
|
|
|
Emodin (30 mg) (1,3,8-trihydroxy-6-methylanthracene-9,10-dione)
|
|
|
Emtricitabine (200 mg)
|
|
|
Emtricitabine System Suitability Mixture A (15 mg)
|
|
|
Emtricitabine System Suitability Mixture B (15 mg)
|
|
|
Enalaprilat (300 mg)
|
|
|
Enalapril Maleate (200 mg)
|
|
|
Enanthic Acid (100 mg) (Heptanoic Acid)
|
|
|
レファレンススタンダードエンドトキシン
|
|
|
エンフルラン
販売終了
|
|
|
Enoxaparin Sodium (300 mg)
|
|
|
Enoxaparin Sodium for Bioassays (COLD SHIPMENT REQUIRED)
販売終了
|
|
|
Enoxaparin Sodium Molecular Weight Calibrant A
販売終了
|
|
|
エノクサパリンナトリウム Molecular Weight Calibrant B
販売終了
|
|
|
Enrofloxacin (200 mg)
|
|
|
Enrofloxacin Related Compound Mixture (50 mg)
|
|
|
Entacapone (200 mg)
|
|
|
Entacapone Related Compound A (25 mg) ((Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide)
|
|
|
Entecavir Monohydrate (200 mg)
|
|
|
Entecavir Related Compound A (15 mg) (9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine)
|
|
|
Entecavir System Suitability Mixture (15 mg) (This is a mixture containing entecavir 1-epimer (0.2%), entecavir (99.6%), 8-hydroxy entecavir (0.1%), and 8-methoxy entecavir (0.1%))
|
|
|
4-Epianhydrotetracycline Hydrochloride (50 mg)
|
|
|
Epicoprostanol (200 mg)
|
|
|
(-)-Epigallocatechin-3-O-gallate (20 mg)
|
|
|
Epilactose (200 mg)
|
|
|
Epinastine Hydrochloride (250 mg)
|
|
|
Epinastine Related Compound A (25 mg) ((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate)
|
|
|
Epinephrine (200 mg)
|
|
|
Epinephrine Bitartrate (200 mg)
|
|
|
Epirubicin Hydrochloride (200 mg)
|
|
|
Eplerenone (250 mg)
|
|
|
Epoprostenol Sodium (100 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Epoprostenol Related Compound A (15 mg) (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid) (COLD SHIPMENT REQUIRED)
|
|
|
Epoprostenol Related Compound B (15 mg) (Sodium 5-(diphenylphosphinoyl)pentanoate)
|
|
|
Eprinomectin (300 mg) (A mixture of component B1a and component B1b) (COLD SHIPMENT REQUIRED)
|
|
|
Equilin (25 mg)
|
|
|
Eprosartan Mesylate (50 mg) ((E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate)
|
|
|
Eprosartan Related Compound A (20 mg) ((E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid hydrochloride)
販売終了
|
|
|
Eprosartan Related Compound B (15 mg) (3-(thiophen-2-yl)propanoic acid)
販売終了
|
|
|
Eprosartan Related Compound C (25 mg) (2-(thiophen-2-ylmethyl)malonic acid)
販売終了
|
|
|
Eprosartan Related Compound D (15 mg) (4-(bromomethyl)benzoic acid)
販売終了
|
|
|
Eprosartan Related Compound E (15 mg) (4-(hydroxymethyl)benzoic acid)
販売終了
|
|
|
Ergocalciferol (30 mg/ampule; 5 ampules) (Vitamin D2)
|
|
|
Ergoloid Mesylates (300 mg)
|
|
|
Ergosterol (50 mg)
|
|
|
Erythorbic Acid (50 mg)
|
|
|
Erythritol (200 mg)
|
|
|
Erythromycin (250 mg)
|
|
|
Erythromycin B (100 mg)
|
|
|
Erythromycin C (50 mg)
|
|
|
Erythromycin Related Compound N (50 mg) (N-Demethylerythromycin A)
|
|
|
Erythromycin Estolate (200 mg)
|
|
|
Erythromycin Ethylsuccinate (200 mg)
|
|
|
Erythromycin Lactobionate (200 mg)
|
|
|
Erythromycin Stearate (200 mg)
|
|
|
Escin (350 mg)
|
|
|
Escitalopram Oxalate (200 mg)
|
|
|
Escitalopram Related Compound A (10 mg) ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate)
|
|
|
Esmolol Hydrochloride (100 mg)
|
|
|
Esomeprazole Magnesium (100 mg)
|
|
|
Esomeprazole Strontium (20 mg)
|
|
|
Estazolam Related Compound A (10 mg) (5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone)
|
|
|
Estradiol (500 mg)
|
|
|
Estradiol Related Compound B (10 mg) (1,3,5(10),6-estratetraen-3,17beta-diol)
|
|
|
Estradiol Related Compound C (15 mg) (1,3,5(10)-estratrien-3,17beta-diol-6-one)
|
|
|
Estradiol Benzoate (250 mg)
|
|
|
Estradiol Cypionate (200 mg)
|
|
|
Estradiol Cypionate System Suitability Mixture (10 mg) (This mixture contains estradiol cypionate, estradiol-9-ene cypionate, estradiol dicypionate, and 4-methylestradiol cypionate)
|
|
|
Estradiol Valerate (100 mg)
|
|
|
Estradiol Valerate Identification Mixture (15 mg)
|
|
|
Estriol (100 mg)
|
|
|
Estriol Related Compound A (25 mg) (Estra-1,3,5(10),9(11)-tetraene-3,16alpha,17Beta-triol)
|
|
|
Estrone (200 mg)
|
|
|
Estropipate (500 mg)
|
|
|
Eszopiclone Related Compound A (10 mg) (6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide)
|
|
|
Ethacrynic Acid (200 mg)
|
|
|
Ethambutol Hydrochloride (200 mg)
|
|
|
Ethambutol Related Compound A (15 mg) ((2R,2'S)-2,2'-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol)dihydrochloride)
|
|
|
Ethambutol Related Compound B (15 mg) (((2R,2'R)-2,2'-[Ethane-1,2-diylbis(azanediyl)]dibutan-1-ol) dihydrochloride)
|
|
|
Ethinyl Estradiol (150 mg)
|
|
|
Ethinyl Estradiol Related Compound A (20 mg) (19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol-6-one)
|
|
|
Ethinyl Estradiol Related Compound B (20 mg) (19-Nor-17alpha-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol monohydrate)
|
|
|
Ethionamide (200 mg)
|
|
|
Ethopabate (125 mg)
|
|
|
Ethopabate Related Compound A (25 mg) (Methyl-4-acetamido-2-hydroxybenzoate)
|
|
|
Ethosuximide (500 mg)
|
|
|
Ethotoin (500 mg)
|
|
|
Ethyl 4-nitrobenzoate (40 mg)
|
|
|
Ethyl Acetate (1.2 mL/ampule; 3 ampules)
|
|
|
Ethyl Acrylate and Methyl Methacrylate Copolymer Dispersion (1.5 g) (Poly(ethyl acrylate-co-methyl methacrylate))
|
|
|
Ethylbenzene (0.5 mL/ampule; 3 ampules)
|
|
|
Ethylcellulose (1 g)
|
|
|
Ethylene Glycol (0.5 mL)
|
|
|
Ethylhexyl Triazone Related Compound A (20 mg) (2-ethylhexyl 4-aminobenzoate)
|
|
|
Ethylhexyl Triazone Related Compound B (4-[(4,6-Bis[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid)
販売終了
|
|
|
Ethylhexyl Triazone Related Compound C (Bis(2-ethylhexyl) 4,4'-[(6-{[4-(ethoxycarbonyl)phenyl]amino}-1,3,5-triazine-2,4-diyl)bis(azanediyl)]dibenzoate)
販売終了
|
|
|
Ethylene Glycol and Vinyl Alcohol Graft Copolymer (1 g)
|
|
|
Ethyl Formate (1.2 mL/ampule; 3 ampules)
|
|
|
1-Ethoxy-2-Methylpropane (3 x 0.2 mL)
|
|
|
Ethyl Laurate (500 mg)
|
|
|
Ethyl Lauroyl Arginate (200 mg)
|
|
|
Ethyl Linoleate (2 x 0.5mL)
|
|
|
Ethyl Maltol (100 mg)
|
|
|
Ethyl Oleate (1 mL)
|
|
|
N-Ethylpiperazine (0.5 mL)
|
|
|
Ethyl Palmitate (500 mg)
|
|
|
Ethylparaben (200 mg)
|
|
|
Ethyl Stearate (100 mg)
|
|
|
Ethyl Vanillin (200 mg)
|
|
|
Ethynodiol Diacetate (200 mg)
|
|
|
Etidronate Disodium Related Compound A (300 mg) (Sodium phosphite dibasic pentahydrate)
|
|
|
Etidronic Acid Monohydrate (1 g)
|
|
|
Etodolac (400 mg)
|
|
|
Etodolac Related Compound A (25 mg) ((+/-)-8-Ethyl-1-methyl-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-acetic acid)
|
|
|
Etomidate (200 mg)
|
|
|
Etonogestrel (100 mg)
|
|
|
Etonogestrel Related Compound A (10 mg) (13-Ethyl-11-methylenegon-4-ene-3,17-dione)
|
|
|
Etoposide (300 mg)
|
|
|
エトポシド Resolution Mixture (10 mg)
|
|
|
Eucalyptol (200 mg)
|
|
|
Eucalyptus Oil (1 g)
|
|
|
Eugenol (5 x 100 mg)
|
|
|
Evening Primrose Oil (1 g)
|
|
|
Ezetimibe (250 mg)
|
|
|
Ezetimibe System Suitability Mixture (20 mg)
|
|
|
Exemestane (150 mg)
|
|
|
Exemestane Related Compound A (15 mg) (6-Methyleneandrosta-4-ene-3,17-dione)
|
|
|
Exemestane Related Compound B (15 mg) (6-hydroxymethylandrostra-1,4-diene-3,17-dione)
|
|
|
Exemestane System Suitability Mixture (25 mg)
|
|
|
Exenatide (2.73 mg)
|
|
|
Ensulizole (200 mg)
|
|
|
FAME Standard Mixture (100 mg) (A mixture of 25 Fatty Acid Methyl Esters)
|
|
|
Famciclovir Related Compound E (25 mg) (2-aminopurine)
|
|
|
Famciclovir Related Compound F (25 mg) (2-Amino-6-chloropurine)
|
|
|
Famciclovir (200 mg)
|
|
|
Famciclovir System Suitability Mixture (20 mg) (Mixture of Famciclovir, Propionyl famciclovir and 6-Chloro famciclovir)
|
|
|
Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol] hydrochloride)
|
|
|
Famciclovir Related Compound B (20 mg) (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate)
|
|
|
Famciclovir Related Compound C (20 mg) (4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate)
|
|
|
Famotidine (125 mg)
|
|
|
Famotidine Related Compound B (25 mg) (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide)
|
|
|
Famotidine Related Compound C (25 mg) (3-[[2-(Diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide hydrochloride)
|
|
|
Famotidine Related Compound D (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide)
|
|
|
Famotidine Related Compound E (25 mg) (2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine)
|
|
|
Famotidine Related Compound F (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid)
|
|
|
Felbamate (250 mg)
|
|
|
Felbamate Related Compound A (25 mg) (3-Hydroxy-2-phenylpropyl carbamate)
|
|
|
Felbamate Related Compound B (25 mg) (Phenethyl carbamate)
|
|
|
Febantel (200 mg)
|
|
|
Febantel Related Compound A (15 mg) (Methyl [[2-[(methoxyacetyl)amino]-4-(phenylthio)phenyl]carbamimidoyl]carbamate)
|
|
|
Febantel Related Compound B (15 mg) (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole)
|
|
|
Felodipine (300 mg)
|
|
|
Felodipine Related Compound A (15 mg) (3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate)
|
|
|
Fenbendazole (100 mg)
|
|
|
Fenbendazole Related Compound A (30 mg) (Methyl (1H-benzimidazole-2-yl)carbamate)
|
|
|
Fenbendazole Related Compound B (30 mg) (Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate)
|
|
|
Fenofibric Acid (250 mg) (2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid)
|
|
|
Fenofibrate (200 mg)
|
|
|
Fenoldopam Mesylate (200 mg)
|
|
|
Fenoldopam Related Compound A (20 mg) (N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride)
|
|
|
Fenoldopam Related Compound B (20 mg) (1-(4-Hydroxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol methanesulfonate)
|
|
|
Fenoprofen Calcium (500 mg)
|
|
|
Fenoprofen Sodium (500 mg)
|
|
|
Fenofibrate Related Compound A (25 mg) ((4-Chlorophenyl)(4-hydroxyphenyl)methanone)
|
|
|
Fenofibrate Related Compound B (25 mg) (2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid)
|
|
|
Fenofibrate Related Compound C (25 mg) (1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate)
|
|
|
Fentanyl Related Compound A (100 mg) ((2-bromoethyl)benzene)
|
|
|
Fentanyl Related Compound D (10 mg) (N-Phenyl-1-(phenylmethyl)-4-piperidinamine)
|
|
|
Ferulic Acid (25 mg)
|
|
|
Ferrous Sulfate (2 x 1 g)
|
|
|
Fexofenadine (200 mg) (2-(4-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid dihydrate)
|
|
|
Fexofenadine Hydrochloride (200 mg)
|
|
|
Fexofenadine Related Compound A (25 mg) (2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid)
|
|
|
Fexofenadine Related Compound B (25 mg) (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate)
|
|
|
Finasteride (200 mg)
|
|
|
Fish Oil (1 g)
|
|
|
Fexofenadine Related Compound C (25 mg) (4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]-1-(4-isopropylphenyl)butan-1-ol hydrochloride)
|
|
|
Fingolimod Hydrochloride (300 mg)
|
|
|
Fingolimod System Suitability Mixture (40 mg)
|
|
|
Flavoxate Hydrochloride (200 mg)
|
|
|
Flavoxate Related Compound A (25 mg) (3-Methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid)
|
|
|
Flavoxate Related Compound B (20 mg) (Methyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate)
|
|
|
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester)
|
|
|
Flax Seed Oil (1 g)
|
|
|
Flecainide Acetate (200 mg)
|
|
|
Flecainide Related Compound A (75 mg) (3-[2,5-Bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8alpha-hexahydroimidazo-[1,5alpha]pyridine hydrochloride)
|
|
|
Floxuridine (250 mg)
|
|
|
Fluconazole (200 mg)
|
|
|
Fluconazole Related Compound A (10 mg) (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol)
|
|
|
Fluconazole Related Compound B (10 mg) (2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol)
|
|
|
Fluconazole Related Compound C (10 mg) (1,1'-(1,3-phenylene)di(1H-1,2,4-triazole))
|
|
|
Flucytosine (200 mg)
|
|
|
Fludarabine Phosphate (300 mg)
|
|
|
Fludeoxyglucose (100 mg)
|
|
|
Fludeoxyglucose Related Compound A (15 mg) (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane)
|
|
|
Fludeoxyglucose Related Compound B (10 mg) (2-chloro-2-deoxy-D-glucose)
|
|
|
Fludrocortisone Acetate (200 mg)
|
|
|
Flumazenil (200 mg)
|
|
|
Flumazenil Related Compound A (20 mg) (8-Fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylic acid)
|
|
|
Flumazenil Related Compound B (20 mg) (Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-a][1,4]benzodiazepine-3-carboxylate)
|
|
|
Flumazenil Related Compound C (500 mg) (N,N-Dimethylformamide diethyl acetal)
|
|
|
ピバル酸フルメタゾン
販売終了
|
|
|
Flunisolide (200 mg)
|
|
|
フルニキシンメグルミン
|
|
|
Flunixin Related Compound A (15 mg) (2-Chloronicotinic acid)
|
|
|
Flunixin Related Compound B (25 mg) (2-Methyl-3-(trifluoromethyl)aniline)
|
|
|
Flunixin Related Compound C (50 mg) (Ethyl 2-chloronicotinate)
|
|
|
Fluocinolone Acetonide (200 mg)
|
|
|
Fluocinonide (200 mg)
|
|
|
Fluorescein (200 mg)
|
|
|
Fluorescein Related Compound C (25 mg) (2-(2,4-Dihydroxybenzoyl)benzoic acid)
|
|
|
Fluoride Dentifrice: Sodium Fluoride/Silica (4.6 oz)
|
|
|
Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder
販売終了
|
|
|
Fluoride Dentifrice: Sodium Monofluorophosphate-Calcium Carbonate
販売終了
|
|
|
Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate (4.6 oz)
|
|
|
Fluoride Dentifrice: Sodium Monofluorophosphate (1000 ppm)/Silica
販売終了
|
|
|
Fluoride Dentifrice: Sodium Monofluorophosphate /Silica (5.25 oz)
販売終了
|
|
|
Fluorometholone (200 mg)
|
|
|
Fluorometholone Related Compound A (15 mg) (11Beta,17alpha-Dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione)
|
|
|
Fluorometholone Acetate (200 mg)
|
|
|
Fluoroquinolonic Acid (150 mg)
|
|
|
Fluorouracil (250 mg)
|
|
|
Fluorouracil Related Compound A (25 mg) (Pyrimidine-2,4,6(1H,3H,5H)-trione)
|
|
|
Fluorouracil Related Compound B (25 mg) (Dihydropyrimidine-2,4,5(3H)-trione)
|
|
|
Fluorouracil Related Compound E (25 mg) (5-Chloropyrimidine-2,4(1H,3H)-dione)
|
|
|
Fluorouracil Related Compound F (25 mg) (2-Ethoxy-5-fluoropyrimidin-4(1H)-one)
|
|
|
Fluoxetine Hydrochloride (200 mg)
|
|
|
Fluoxetine Related Compound A (15 mg) (N-Methyl-3-phenyl-3-[3-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride)
|
|
|
Fluoxetine Related Compound B (5 mL of a 0.01N HCl Solution, approx. 2 mg/mL) (N-Methyl-3-phenylpropan-1-amine)
|
|
|
Fluoxetine Related Compound C (15 mg) (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid)
|
|
|
Fluphenazine Decanoate Dihydrochloride (100 mg)
|
|
|
Fluphenazine Enanthate Dihydrochloride (125 mg)
|
|
|
Fluphenazine Hydrochloride (125 mg)
|
|
|
Foeniculin (4 x 50 mg)
|
|
|
Fondaparinux Sodium for Assay (0.6 mL) (COLD SHIPMENT REQUIRED)
|
|
|
Fondaparinux Sodium Identification (30 mg)
|
|
|
フォンダパリヌクスナトリウムシステム適合性 Mixture A (2.5 mg) (PLANNED TO BE DISCONTINUED)
販売終了
|
|
|
Fondaparinux Sodium System Suitability Mixture B (2.5 mg) (A mixture containing fondaparinux sodium and fondaparinux related compound A, B, C, D, E, F, and G)
|
|
|
Formic Acid (1.2 mL/ampule; 3 ampules)
|
|
|
Forskolin (40 mg) (7Beta-acetoxy-8,13-epoxy-1alpha,6Beta,9alpha-trihydroxy-labd-14-en-11-one)
|
|
|
Foscarnet Sodium (50 mg) (Phosphonoformic acid, trisodium salt, hexahydrate)
|
|
|
Foscarnet Related Compound B (10 mg) (disodium (ethoxyoxidophosphanyl)formate)
|
|
|
Foscarnet Related Compound D (0.27 mL) (O,O-diethyl ethoxycarbonylphosphonate)
|
|
|
Fosinopril Sodium (200 mg)
|
|
|
Fosinopril Related Compound A (25 mg) ((4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline)
|
|
|
Fosinopril Related Compound B (25 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate)
|
|
|
Fosinopril Related Compound C (15 mg) ((4S)-4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-L-proline propionate (ester), sodium salt)
|
|
|
Fosinopril Related Compound D (15 mg) ((4R)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
|
|
|
Fosinopril Related Compound E (15 mg) ((4S)-4-Phenyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
|
|
|
Fosinopril Related Compound F (15 mg) ((4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate(ester), sodium salt)
|
|
|
Fosinopril Related Compound G (15 mg) ((4-phenylbutyl)phosphinyl acetic acid, disodium salt)
|
|
|
Fosinopril Related Compound H (25 mg) (4-phenylbutyl phosphonic acid)
|
|
|
Flurandrenolide (100 mg)
|
|
|
Flurazepam Related Compound C (50 mg) (5-Chloro-2-(2-diethylaminoethylamino)-2'-fluorobenzophenone hydrochloride)
|
|
|
Flurazepam Related Compound F (50 mg) (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
|
|
|
Flurbiprofen (200 mg)
|
|
|
Flurbiprofen Related Compound A (100 mg) (2-(4-Biphenylyl)propionic Acid)
|
|
|
Flurbiprofen Sodium (200 mg)
|
|
|
Fluticasone Propionate Related Compound D (15 mg) (S-methyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxyandrosta-1,4-diene-17beta-carbothioate)
|
|
|
Fluticasone Propionate Related Compounds Mixture (25 mg)
|
|
|
Flutamide (200 mg)
|
|
|
o-Flutamide (50 mg)
|
|
|
Fluticasone Propionate (100 mg)
|
|
|
Fluticasone Propionate Resolution Mixture
販売終了
|
|
|
Fluticasone Propionate System Suitability Mixture (25 mg) (Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D)
|
|
|
Fluvoxamine Maleate (200 mg)
|
|
|
Fluticasone Propionate Nasal Spray Resolution Mixture (25 mg)
|
|
|
Fluvastatin Sodium (2 x 350 mg)
|
|
|
Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt))
|
|
|
Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester)
|
|
|
Flutamide Related Compound B (20 mg) (N-[4-nitro-3-(trifluoromethyl)phenyl]acetamide)
|
|
|
Flutamide Related Compound A (20 mg) (4-nitro-3-(trifluoromethyl)aniline)
|
|
|
Folic Acid (500 mg) (Vitamin M or Vitamin Bc)
|
|
|
Formononetin (50 mg)
|
|
|
10-Formylfolic Acid (25 mg) (L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]formylamino-]benzoyl]-)
|
|
|
Fosfomycin Tromethamine (800 mg)
|
|
|
Fosphenytoin Sodium (350 mg)
|
|
|
Frovatriptan Racemate (15 mg)
|
|
|
Frovatriptan Succinate (200 mg)
|
|
|
Frovatriptan Related Compound A (20 mg) ((R)-3-Amino-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide)
|
|
|
Fructose (125 mg)
|
|
|
L-Fucose (200 mg)
|
|
|
Fulvestrant (200 mg)
|
|
|
Fulvestrant System Suitability Mixture (30 mg)
|
|
|
Fumaric Acid (200 mg)
|
|
|
Furazolidone (200 mg)
|
|
|
Furosemide (200 mg)
|
|
|
Furosemide Related Compound A (50 mg) (2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid)
|
|
|
Furosemide Related Compound B (100 mg) (4-Chloro-5-sulfamoylanthranilic Acid)
|
|
